I received very clear answers to my questions from Sarah this evening. See below. 

Will the results of the SSRA be announced or will Resverlogix keep them confidential? Yes it would be press released.

Will the BIO International slides be posted? Yes – tomorrow morning.

Is Resverlogix still blinded in BETonMACE? Yes.

Is the apabetalone dosing period in BETonMACE 104 weeks as stated previously or did it change as suggested in Dr. Kalantar-Zadeh's recent ERA-EDTA poster to up to 36 months? All patients will now stay on drug until the trial is completed. The longest enrolled patient is now at 31 months.